PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...

Descrizione completa

Dettagli Bibliografici

Autore principale:	M. V. Protsenko
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	IRBIS LLC 2015-03-01
Serie:	Фармакоэкономика
Soggetti:	primary open-angle glaucoma pharmacoeconomic studies cost-utility analysis willingness-to-pay analysis cost minimization analysis budget impact analysis timolol brinzolamid
Accesso online:	https://www.pharmacoeconomics.ru/jour/article/view/38
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!